Results 81 to 90 of about 3,591 (202)
, 2017 120 Background: Antiemetic trials typically evaluate CINV control during acute (Day 1), delayed (Days 2-5), and overall (Days 1-5) phases post-chemotherapy; the daily course of events is often unstudied in the delayed phase.
Corinna Lanzarotti +4 more
core +1 more source
, 2019 Introduction Preventing CINV is possible when guideline-recommended antiemetics are used. Because oncology nurses play a critical role in risk assessment and management of CINV, a survey of European nurses was conducted to evaluate antiemetic practices ...
Dielenseger, Pascale, +4 more
core +1 more source
Is Rolapitant Effective in Reducing the Incidence of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients Receiving Emetogenic Chemotherapy? [PDF]
, 2017 Objective: The objective of this selective EBM review is to determine whether or not rolapitant is safe and effective in reducing the incidence of chemotherapy induced nausea and vomiting (CINV) in patients receiving emetogenic chemotherapy. Study Design:
Eberts, Brandon E
core +1 more source
Indian Journal of Medical and Paediatric Oncology, 2019 Chemotherapy-induced nausea and vomiting (CINV) is a significant contributor to the treatment morbidity experienced by patients with cancer. With effective prophylactic anti-emetics given prior to administration of moderately or highly emetogenic ...
Venkatraman Radhakrishnan
doaj +1 more source
Olanzapine: is it enough for CINV prevention? [PDF]
Annals of Palliative Medicine, 2020 Piyawan, Tienchaiananda +2 more
openaire +2 more sources
Abstracts of 14th International Symposium on Hodgkin Lymphoma
HemaSphere, Volume 10, Issue S2, October 2026.
wiley +1 more source
A study on utilization and evaluation of antiemetics in chemotherapy-induced nausea and vomiting
Indian Journal of Medical and Paediatric Oncology, 2017 Purpose: Chemotherapy-induced nausea and vomiting (CINV) are the major adverse effects of cancer chemotherapy. The objectives of this study are to evaluate the utilization of antiemetics in CINV and to assess the emetogenicity of chemotherapy and to ...
Gayathri Baburaj +6 more
doaj +1 more source
Therapeutics and Clinical Risk Management, 2016 Vito Lorusso National Cancer Research Centre, Istituto Tumori Giovanni Paolo II, Bari, Italy Abstract: As recommended by most recent antiemetic guidelines, the optimal prophylaxis of chemotherapy-induced nausea and vomiting (CINV) requires the ...
Lorusso V
doaj
Aromatherapy in Oncology: Effects and Reduction of CINV in Adult Patients
Einleitung: Chemotherapie-induzierte Übelkeit und Erbrechen (CINV) zählen zu den häufigsten und belastendsten Nebenwirkungen onkologischer Therapien und beeinträchtigen die Lebensqualität der Betroffenen erheblich.
Beiß, Denise
core +2 more sources
, 2012 167 Background: Electronic Health Records (EHRs) are a valuable source to evaluate the quality of oncology care, particularly when combined with patient outcomes data.
Nancy Walker Peacock +11 more
core +1 more source